Trial Profile
Comparative Effects of Nebivolol Versus Metoprolol on 24-Hour Blood Pressures and Basal Metabolic Rate: An Open-Label Study.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2013
Price :
$35
*
At a glance
- Drugs Metoprolol (Primary) ; Nebivolol (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 06 Apr 2011 Added actual number of patients, as reported by ClinicalTrials.gov.
- 06 Apr 2011 Status changed from recruiting to discontinued, according to ClinicalTrials.gov..
- 13 Jan 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.